Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Cassava Sciences, Inc.
Penalty: $40,000,000
Year: 2024
Date: September 26, 2024
Offense Group: financial offenses
Primary Offense: investor protection violation
Violation Description: Cassava Sciences, Inc. agreed to pay $40 million to settle charges related to misleading statements made in September 2020 about the results of a Phase 2 clinical trial for the company's purported therapeutic for the treatment of Alzheimer's disease.
Level of Government: federal
Action Type: agency action
Agency: Securities and Exchange Commission
Civil or Criminal Case: civil
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.